GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OBI Pharma Inc (ROCO:4174) » Definitions » Sale Of Investment

OBI Pharma (ROCO:4174) Sale Of Investment : NT$1,816.13 Mil (TTM As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is OBI Pharma Sale Of Investment?

OBI Pharma's sale of investment for the three months ended in Sep. 2024 was NT$0.00 Mil. It means OBI Pharma gained NT$0.00 Mil from selling investments. OBI Pharma's sale of investment for the trailing twelve months (TTM) ended in Sep. 2024 was NT$1,816.13 Mil.

Compared with last quarter (NT$1,026.20 Mil in Jun. 2024 ), OBI Pharma gained less money from selling investments in Sep. 2024 (NT$0.00 Mil).

OBI Pharma Sale Of Investment Historical Data

The historical data trend for OBI Pharma's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OBI Pharma Sale Of Investment Chart

OBI Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 140.00 983.04

OBI Pharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 789.93 1,026.20 -

OBI Pharma Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,816.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OBI Pharma Sale Of Investment Related Terms

Thank you for viewing the detailed overview of OBI Pharma's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

OBI Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OBI Pharma Inc (ROCO:4174) » Definitions » Sale Of Investment
Comparable Companies
ROCO:6976 ROCO:6617 ROCO:4162 ROCO:4147 ROCO:6712 ROCO:6919 ROCO:6547 ROCO:6586 TPE:4142 ROCO:4728 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No. 3, Park Street, Room 1907, 19th Floor, Nangang District, Taipei, TWN, 115
Website
https://www.obipharma.com
OBI Pharma Inc is part of the healthcare sector. The company and its subsidiaries are engaged in new drug research. Its focus is on the unmet medical need in challenging diseases throughout the world, such as cancer. OBI strives to improve health and the quality of life through cost-effective therapeutics. The group has four reportable segments, which are the anti-cancer new drug segment, bispecific monoclonal antibody new drug segment, botulinum toxin new drug segment, and CDMO segment.

OBI Pharma Headlines

No Headlines